Amylyx Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AMLX on Nasdaq
Insider Purchase
+$9,450
+new%
Shares
Shares Volume: 5,000 Shares
Average Share Price: $1.89
INSIDER
Quimi Daphne
Director
reported on May 16 2024
traded on May 14 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 5,000 |
PURCHASES/SALES 1Y | 1 / 0 |
P/S VALUE RATIO | n/a |
AVERAGE PURCHASE VALUE | $9,450 |
INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 1 |
PURCHASES/SALES 1Y | 2 / 9 |
P/S VALUE RATIO | 0.04 |
AVERAGE PURCHASE VALUE | $34,665 |
COMPANY PREVIOUS TRADES |